Note: All prices and reports are based on end of the day (EOD) data.
Glenmark Life Sciences Limited (GLS)
What GLS does

Glenmark Life Sciences Limited

What company does?Manufactures active pharmaceutical ingredients (APIs) for the pharmaceutical industry.
Established2011
Entity typePrivate
HeadquartersIndia
SegmentB2B
Glenmark Life Sciences Limited is a share market listed company in the Healthcare industry . It got listed on NSE on 06-AUG-2021 under the trading symbol GLS. On BSE it is listed under trading symbol GLS. The company operates in Pharmaceuticals , Chemical Manufacturing and Biotechnology categories.

Company overview

Glenmark Life Sciences Limited is a leading developer and manufacturer of active pharmaceutical ingredients (APIs). The company specializes in the production of high-quality, cost-effective APIs for various therapeutic areas including cardiovascular, central nervous system, anti-infectives, and oncology. With a strong focus on research and development, Glenmark Life Sciences has established itself as a reliable partner for global pharmaceutical companies.

The company's product portfolio includes a wide range of APIs that are used in the formulation of generic drugs. These APIs are manufactured at state-of-the-art facilities that adhere to stringent quality standards and regulatory requirements.

One aspect that sets Glenmark Life Sciences apart from its competitors is its commitment to innovation and sustainability. The company leverages advanced technologies and processes to drive efficiency in API manufacturing while minimizing environmental impact. This dedication to sustainable practices not only benefits the environment but also positions the company as a responsible player in the pharmaceutical industry.

Glenmark Life Sciences' emphasis on research and development has led to several innovative technologies being implemented within its operations. By continuously investing in R&D, the company aims to introduce new products and improve existing processes, thereby staying ahead in an increasingly competitive market.

In terms of collaborations and partnerships, Glenmark Life Sciences has engaged with various global pharma majors for co-developing molecules or supplying APIs for their drug formulations. These strategic alliances have contributed significantly to the company's growth trajectory by expanding its reach across international markets. Overall, Glenmark Life Sciences Limited stands out due to its unwavering commitment to producing high-quality APIs through innovation-driven approaches while prioritizing sustainability. Its ability to forge strategic partnerships further strengthens its position as a key player in the global pharmaceutical landscape.
Disclaimer :

All prices or any other data provided here is based on previous day's closing price.

Trading or investing involves a high level of risk, including the loss of all of your investment. No information on our website should be interpreted as an investment / trading suggestion. We are not providing any kind of financial tips or recommendations. We just provide the data that you can analyse yourself and make your own decision. You are solely responsible for any of your action.

We are not SEBI registered analysts. Our website or any person associated with our website are not liable for any kind of losses, fees or charges etc.

We have tried our best to keep the data accuracy. But still we don't guarantee that our data is accurate and up to date. Verify the accuracy of data from official sources like NSE and BSE websites.

Any brand names, trademarks, or copyrighted materials used on this website are for informational purposes only. We disclaim any ownership or rights to such third-party copyrighted materials.

Stocklyzer

At stocklyzer, we provide financial tools, guides and data analysis to help you to make your decision in the financial market.

Contact us
Contact us for any kind of inquiry contact@stocklyzer.com Contact form
Stocklyzer.com © Copyright 2023. All Rights Reserved.